BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 25721084)

  • 1. The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma.
    Yang X; Xie X; Xiao YF; Xie R; Hu CJ; Tang B; Li BS; Yang SM
    Cancer Lett; 2015 May; 360(2):119-24. PubMed ID: 25721084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.
    Panzitt K; Tschernatsch MM; Guelly C; Moustafa T; Stradner M; Strohmaier HM; Buck CR; Denk H; Schroeder R; Trauner M; Zatloukal K
    Gastroenterology; 2007 Jan; 132(1):330-42. PubMed ID: 17241883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
    Eguchi H; Doki Y; Mori M
    Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma.
    Huang JL; Zheng L; Hu YW; Wang Q
    Carcinogenesis; 2014 Mar; 35(3):507-14. PubMed ID: 24296588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.
    Zhang H; Zhu C; Zhao Y; Li M; Wu L; Yang X; Wan X; Wang A; Zhang MQ; Sang X; Zhao H
    Oncotarget; 2015 Dec; 6(41):43770-8. PubMed ID: 26540467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
    Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs: critical players in hepatocellular carcinoma.
    Sun J; Bie B; Zhang S; Yang J; Li Z
    Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
    George J; Patel T
    Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2.
    Wang F; Yuan JH; Wang SB; Yang F; Yuan SX; Ye C; Yang N; Zhou WP; Li WL; Li W; Sun SH
    Hepatology; 2014 Oct; 60(4):1278-90. PubMed ID: 25043274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action.
    Shi X; Zhu HR; Liu TT; Shen XZ; Zhu JM
    Cancer Lett; 2017 Aug; 400():175-182. PubMed ID: 28461246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.
    Law PT; Qin H; Ching AK; Lai KP; Co NN; He M; Lung RW; Chan AW; Chan TF; Wong N
    J Hepatol; 2013 Jun; 58(6):1165-73. PubMed ID: 23376363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
    Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
    Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells.
    Huo X; Han S; Wu G; Latchoumanin O; Zhou G; Hebbard L; George J; Qiao L
    Mol Cancer; 2017 Oct; 16(1):165. PubMed ID: 29061150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNAs in liver cancer: what we know in 2014.
    Zhao J; Greene CM; Gray SG; Lawless MW
    Expert Opin Ther Targets; 2014 Oct; 18(10):1207-18. PubMed ID: 25145388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.
    Klingenberg M; Matsuda A; Diederichs S; Patel T
    J Hepatol; 2017 Sep; 67(3):603-618. PubMed ID: 28438689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.
    Parasramka MA; Maji S; Matsuda A; Yan IK; Patel T
    Pharmacol Ther; 2016 May; 161():67-78. PubMed ID: 27013343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
    Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
    Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
    Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
    Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.